Profile data is unavailable for this security.
About the company
Medios AG, formerly Crevalis Capital AG, is a Germany-based company that is active in the pharmacy business. It wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The Company also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.
- Revenue in EUR (TTM)1.81bn
- Net income in EUR17.97m
- Incorporated1999
- Employees500.00
- LocationMedios AGHeidestrasse 9BERLIN 10557GermanyDEU
- Phone+49 30 232566800
- Fax+49 30 232566801
- Websitehttps://medios.ag/
More ▼
Mergers & acquisitions
| Acquired company | ILM1X:GER since announced | Transaction value |
|---|---|---|
| Ceban Pharmaceuticals BV | 25.79% | 282.65m |
Data delayed at least 15 minutes, as of Jul 24 2024 08:02 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medios AG | 1.81bn | 17.97m | 451.45m | 500.00 | 23.24 | 0.8907 | 11.59 | 0.2495 | 0.7615 | 0.7615 | 76.55 | 19.87 | 2.90 | 27.80 | 13.71 | 3,513,961.00 | 2.88 | 3.40 | 3.46 | 4.07 | 5.99 | 6.05 | 0.9931 | 1.01 | 2.15 | 16.94 | 0.0347 | 0.00 | 10.80 | 40.34 | 2.62 | 34.17 | -7.11 | -- |
| Theravance Biopharma Inc | 56.68m | -41.25m | 451.69m | 99.00 | -- | 2.39 | -- | 7.97 | -0.861 | -0.861 | 1.19 | 4.22 | 0.1352 | -- | 4.57 | 621,313.10 | -9.84 | -40.51 | -10.39 | -48.50 | -- | -- | -72.78 | -305.27 | -- | -- | 0.00 | -- | 11.84 | -0.9956 | 40.54 | -- | -19.24 | -- |
| Pharmanutra SpA | 100.32m | 10.83m | 456.46m | 111.00 | 41.76 | 7.95 | 33.39 | 4.55 | 1.13 | 1.13 | 10.43 | 5.93 | 0.9123 | 0.5233 | 4.00 | 955,428.60 | 9.85 | 18.39 | 13.20 | 24.80 | 95.92 | 96.36 | 10.79 | 17.77 | 1.87 | 34.93 | 0.3324 | 52.51 | 21.13 | 16.51 | -14.73 | 8.44 | 75.71 | 11.20 |
| Eyepoint Pharmaceuticals Inc | 46.09m | -72.71m | 459.03m | 121.00 | -- | 1.91 | -- | 9.96 | -1.83 | -1.83 | 1.17 | 5.01 | 0.2068 | 1.14 | 7.44 | 413,380.20 | -32.62 | -40.44 | -40.06 | -47.79 | 90.50 | 83.45 | -157.77 | -186.23 | 5.01 | -- | 0.00 | -- | 11.14 | -- | 30.77 | -- | -- | -- |
| Shanghai New World Co Ltd | 145.02m | 4.25m | 459.63m | 1.20k | 108.05 | 0.8633 | -- | 3.17 | 0.0519 | 0.0519 | 1.77 | 6.50 | 0.2026 | 4.62 | 7.42 | 951,798.10 | 0.5858 | 0.5242 | 0.78 | 0.7249 | 38.56 | 33.70 | 2.89 | 2.71 | 1.52 | -- | 0.1222 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
| Medincell SA | 10.85m | -26.42m | 462.55m | 138.00 | -- | -- | -- | 42.64 | -1.02 | -1.02 | 0.4086 | -0.8965 | 0.2605 | -- | 6.81 | -- | -63.46 | -- | -115.15 | -- | 60.43 | -- | -243.58 | -366.40 | -- | -4.29 | 1.69 | -- | -8.67 | 44.33 | 21.78 | -- | -- | -- |
| Clinuvel Pharmaceuticals Limited | 53.20m | 18.38m | 463.94m | 16.00 | 26.10 | 4.26 | 24.44 | 8.72 | 0.5825 | 0.5825 | 1.69 | 3.56 | 0.4693 | -0.9514 | 7.35 | -- | 16.21 | 21.25 | 18.57 | 23.55 | 109.28 | -- | 34.54 | 41.84 | 6.43 | 14.53 | 0.006 | 7.44 | 24.27 | 26.14 | 46.58 | 18.27 | 68.74 | 20.11 |
| Soho Global Health Tbk PT | 487.94m | 25.04m | 472.53m | 2.32k | 18.87 | 3.29 | 16.33 | 0.9684 | 34.71 | 34.71 | 676.37 | 198.99 | 1.77 | 5.67 | 4.97 | 3,617,495,000.00 | 9.06 | 7.97 | 16.53 | 14.37 | 16.24 | 19.39 | 5.13 | 4.65 | 1.26 | -- | 0.006 | -- | 12.45 | 12.43 | 4.10 | 49.70 | 21.21 | -- |
Data as of Jul 24 2024. Currency figures normalised to Medios AG's reporting currency: Euro EUR
22.45%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Paladin Asset Management Investmentaktiengesellschaft TGVas of 12 Feb 2024 | 1.19m | 4.67% |
| SEB Investment Management AB (Denmark)as of 28 Feb 2023 | 1.12m | 4.39% |
| Allianz Global Investors GmbHas of 29 Jan 2024 | 700.14k | 2.75% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 513.30k | 2.01% |
| Cr�dit Mutuel Asset Management SAas of 29 Dec 2023 | 494.31k | 1.94% |
| Mandatum Life Sijoituspalvelut Oyas of 30 Jun 2023 | 487.87k | 1.91% |
| Oddo BHF Asset Management SASas of 28 Jun 2024 | 381.43k | 1.50% |
| Skandinaviska Enskilda Banken AB (Denmark)as of 28 Jun 2024 | 288.87k | 1.13% |
| Kreissparkasse Biberachas of 30 Apr 2024 | 280.00k | 1.10% |
| DNCA Finance SAas of 30 Jun 2023 | 270.42k | 1.06% |
More ▼
Data from 30 Jun 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
